This multicenter, double-blind, randomized, parallel-group fixed-dose study of 8 weeks' duration was performed to define the maximum tolerated dose of nateglinide in a prediabetic population.

Levy JC. Randomized dose ranging study of the reduction of fasting and postprandial glucose in type 2 diabetes by nateglinide (A-4166). Diabetes Care. 2001 Jul;24(7):1221-5. [4]Shukla AP ...

The goal of this study was to assess the safety, tolerability, and metabolic effects of nateglinide in a prediabetic population and to thereby establish the feasibility of using nateglinide for a ...

However, its acute glucose lowering effect is comparable to other diabetic medications like Acarbose and Nateglinide. This doesn’t mean people should stop taking medications and do food order ...